Verily, which is formerly known as Google’s Life Sciences, announced a partnership with Johnson & Johnson to create a surgical solutions company they call Verb Surgical, which focus on the development of robotic and surgical platforms for the medical industry.
In a press release that was released by J&J, the team outlines their goals: “In the coming years, Verb Surgical aims to develop a comprehensive surgical solutions platform that will incorporate leading-edge robotic capabilities and best-in-class medical device technology for operating room professionals. The goal of Verb Surgical is to develop these new technologies in partnership with surgeons and hospitals to enable better patient outcomes, improve access to minimally invasive surgery, and achieve greater hospital efficiency.”
The release added that the aim of Verb Surgical will be to bring together “ leading-edge robotic capabilities” and “best-in-class medical device technology” in the operating room.
“We believe Verb Surgical has the potential to change the future of surgery, not just robotic surgery,” said Gary Pruden, Worldwide Chairman, Johnson & Johnson Medical Devices. “The team has already made meaningful progress on the robotics platform, which is being developed for application across a host of surgical specialties.”
This is the first company that Verily has partnered with, which could pave the way for future partnerships across various other industries, including biotech, pharma, diagnostics, patient advocacy and the academe.